NCT07166094
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07166094
Title Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer (RAINFOL-03)
Acronym RAINFOL-03
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Trials365, LLC RECRUITING Shreveport Louisiana 71103 United States Details
Sinai Hospital RECRUITING Baltimore Maryland 21215 United States Details
William Kahlert Reg. Can. Ctr RECRUITING Westminster Maryland 21157 United States Details
USOR - Texas Oncology - Dallas Fort Worth (DFW) RECRUITING Fort Worth Texas 76104 United States Details
Fukushima Medical University Hospital RECRUITING Fukushima 960-1247 Japan Details
Niigata Cancer Center Hospital RECRUITING Niigata Japan Details
Saitama Medical University - International Medical Center RECRUITING Saitama 350-1298 Japan Details
Osaka Medical and Pharmaceutical University Hospital RECRUITING Takatsuki 569-8686 Japan Details
Cancer Institute Hospital of JFCR RECRUITING Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field